Yamanaka N - Search Results

1

Immunohistochemical staining of hedgehog pathway-related proteins in human thymomas.

Tasaki A, Akiyoshi T, Koga K, Nakashima H, Yamanaka N, Kubo M, Matsumoto K, Kojima M, Tanaka M, Nakamura M, Katano M. Tasaki A, et al. Among authors: yamanaka n. Anticancer Res. 2005 Nov-Dec;25(6A):3697-701. Anticancer Res. 2005. PMID: 16302728 Free article.

2

Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.

Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S, Katano M. Kubo M, et al. Among authors: yamanaka n. Cancer Res. 2004 Sep 1;64(17):6071-4. doi: 10.1158/0008-5472.CAN-04-0416. Cancer Res. 2004. PMID: 15342389

3

Purification, characterization and biological significance of tumor-derived exosomes.

Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M. Koga K, et al. Among authors: yamanaka n. Anticancer Res. 2005 Nov-Dec;25(6A):3703-7. Anticancer Res. 2005. PMID: 16302729 Free article.

4

Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.

Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M, Katano M. Nakashima H, et al. Among authors: yamanaka n. Cancer Res. 2006 Jul 15;66(14):7041-9. doi: 10.1158/0008-5472.CAN-05-4588. Cancer Res. 2006. PMID: 16849549

5

Hedgehog signaling pathway is a possible therapeutic target for gastric cancer.

Yanai K, Nagai S, Wada J, Yamanaka N, Nakamura M, Torata N, Noshiro H, Tsuneyoshi M, Tanaka M, Katano M. Yanai K, et al. Among authors: yamanaka n. J Surg Oncol. 2007 Jan 1;95(1):55-62. doi: 10.1002/jso.20606. J Surg Oncol. 2007. PMID: 17192867

6

Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer.

Kubo M, Morisaki T, Kuroki H, Tasaki A, Yamanaka N, Matsumoto K, Nakamura K, Onishi H, Baba E, Katano M. Kubo M, et al. Among authors: yamanaka n. Anticancer Res. 2003 Nov-Dec;23(6a):4443-9. Anticancer Res. 2003. PMID: 14666732

7

Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation.

Yamanaka N, Morisaki T, Nakashima H, Tasaki A, Kubo M, Kuga H, Nakahara C, Nakamura K, Noshiro H, Yao T, Tsuneyoshi M, Tanaka M, Katano M. Yamanaka N, et al. Clin Cancer Res. 2004 Mar 1;10(5):1853-9. doi: 10.1158/1078-0432.ccr-03-0300. Clin Cancer Res. 2004. PMID: 15014040

8

Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma.

Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, Noshiro H, Yao T, Tsuneyoshi M, Tanaka M, Katano M. Yamanaka N, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1071-5. Anticancer Res. 2004. PMID: 15154625 Free article.

9

Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells.

Tasaki A, Yamanaka N, Kubo M, Matsumoto K, Kuroki H, Nakamura K, Nakahara C, Onishi H, Kuga H, Baba E, Tanaka M, Morisaki T, Katano M. Tasaki A, et al. Among authors: yamanaka n. J Immunol Methods. 2004 Apr;287(1-2):79-90. doi: 10.1016/j.jim.2004.01.014. J Immunol Methods. 2004. PMID: 15099757

10

Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.

Kubo M, Morisaki T, Matsumoto K, Tasaki A, Yamanaka N, Nakashima H, Kuroki H, Nakamura K, Nakamura M, Katano M. Kubo M, et al. Among authors: yamanaka n. Cancer Immunol Immunother. 2005 May;54(5):468-76. doi: 10.1007/s00262-004-0617-6. Epub 2004 Dec 9. Cancer Immunol Immunother. 2005. PMID: 15592829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters